Does chemotherapy increase the risk of respiratory complications after pneumonectomy?

Journal of Thoracic and Cardiovascular Surgery

Volumn 132, Issue 3, 2006, Pages 519-523

  Leo, Francesco ^a   Solli, PierGiorgio ^a   Veronesi, Giulia ^a   Radice, Davide ^a   Floridi, Antonio ^a   Gasparri, Roberto ^a   Petrella, Francesco ^a   Borri, Alessandro ^a   Galetta, Domenico ^a   Spaggiari, Lorenzo ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CISPLATIN; GEMCITABINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ATELECTASIS; BLEEDING; BLOOD TRANSFUSION; BODY MASS; BRONCHUS FISTULA; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; HEART ATRIUM FIBRILLATION; HEMATOTHORAX; HUMAN; HYPOTHESIS; INFORMATION PROCESSING; LOGISTIC REGRESSION ANALYSIS; LUNG CANCER; LUNG DIFFUSION CAPACITY; LUNG EDEMA; LUNG EMBOLISM; LUNG PERFUSION; LUNG RESECTION; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OPERATION DURATION; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SURGICAL MORTALITY; SURGICAL TECHNIQUE; UNIVARIATE ANALYSIS;

FEMALE; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; RESPIRATION DISORDERS; RISK FACTORS;

EID: 33747769695     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.05.012     Document Type: Article

References (21)

1. Graham E.A., and Singer J.J. Successful removal of an entire lung for carcinoma of the bronchus. JAMA 101 (1933) 1371-1374
2. Fell S.C. A history of pneumonectomy. Chest Surg Clin 9 (1999) 267-290
3. Overholt R. Pneumonectomy for malignant and suppurative disease of the lung. J Thorac Cardiovasc Surg 9 (1939) 17
4. Ginsberg R.J., Hill L.D., Eagan R.T., Thomas P., Mountain C.F., Deslauriers J., et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 86 (1983) 654-658
5. Roberts J.R., Eustis C., Devore R., Carbone D., Choy H., and Johnson D. Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer. Ann Thorac Surg 72 (2001) 885-888
6. Novoa N., Varela G., and Jimenez M.F. Morbidity after surgery for non-small cell lung carcinoma is not related to neoadjuvant chemotherapy. Eur J Cardiothorac Surg 20 (2001) 700-704
7. Stover DE, Kaner RJ. Adverse effects of treatment: pulmonary toxicity. In: De Vita VT, Hellman S, Rosenberg AA, Cancer. Principles & practice of oncology, 7th ed. Philadelphia: Lippincott Williams & Wilkins; p. 2539-45.
8. Amato M.B., Barbas C.S., Medeiros D.M., Magaldi R.B., Schettino G.P., Lorenzi-Filho G., et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 5 (1998) 347-354 338
9. Bernard G.R., Artigas A., Brigham K.L., Carlet J., Falke K., Hudson L., et al. The American European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149 (1994) 818-824
10. Martin J., Ginsberg R.J., Abolhoda A., Bains M.S., Downey R.J., Korst R.J., et al. Morbidity and mortality after neoadjuvant therapy for lung cancer. the risks of right pneumonectomy. Ann Thorac Surg 72 (2001) 1149-1154
11. Leo F., Solli P., Spaggiari L., Veronesi G., de Braud F., Leon M.E., et al. Respiratory function changes after chemotherapy. an additional risk for postoperative respiratory complications?. Ann Thorac Surg 77 (2004) 260-265
12. Wang J., Olak J., and Ferguson M.K. Diffusing capacity predicts operative mortality but not long-term survival after resection for lung cancer. J Thorac Cardiovasc Surg 117 (1999) 581-587
13. Cerfolio R.J., Allen M.S., Trastek V.F., Deschamps C., Scanlon P.D., and Pairolero P.C. Lung resection in patients with compromised pulmonary function. Ann Thorac Surg 62 (1996) 348-351
14. Maas K.W., van der Lee I., Bolt K., Zanen P., Lammers J.W.J., and Schramel F.M.N.H. Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment. Lung Cancer 41 (2003) 345-351
15. Mizushima Y., Noto H., Sugiyama S., Kusajima Y., Yamashita R., Kashii T., et al. Survival and prognosis after pneumonectomy for lung cancer in the elderly. Ann Thorac Surg 64 (1997) 193-198
16. Nagasaki F., Flehinger B.J., and Martini N. Complications of surgery in the treatment of carcinoma of the lung. Chest 1 (1982) 25-29
17. Romano P.S., and Mark D.H. Patients mortality and hospital characteristics related to in-hospital mortality after lung resections. Chest 101 (1992) 1332-1337
18. Dulu A., Pastores S.M., Park B., Halpern N.A., and Rusch V. Prevalence and mortality of acute lung injury and acute respiratory distress syndrome after lung resection. Chest 128 (2005) 207S
19. Allen M.S., Darling G.E., Pechet T.T., Mitchell J.D., Herndon J.E., Landreneau R.J., et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer. initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 81 (2006) 1013-1020
20. Rosell R., Gomez-Codina J., Camps C., Maestre J., Padille J., Canto A., et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330 (1994) 153-158
21. Roth J.A., Fossella F., Komaki R., Ryan M.B., Putnam Jr. J.B., Lee J.S., et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 86 (1994) 673-680